Phase II trial of biochemotherapy with interferon α, dacarbazine, cisplatin and tamoxifen in metastatic melanoma: A Southwest Oncology Group trial

Kim A. Margolin, P. Y. Liu, Joseph M. Unger, William S. Fletcher, Lawrence E. Flaherty, Walter J. Urba, Evan M. Hersh, Laura E. Hutchins, Jeffrey A. Sosman, John W. Smith, Geoffrey R. Weiss, Vernon K. Sondak

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of biochemotherapy with interferon α, dacarbazine, cisplatin and tamoxifen in metastatic melanoma: A Southwest Oncology Group trial'. Together they form a unique fingerprint.

Medicine & Life Sciences